ArticleIranian journal of biotechnology2025
Cardiac Troponin I Promotes the Development of NSCLC Cells Through the Expression of Notch and Kras Proteins.
Article in Iranian journal of biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Mechanism of lovastatin in promoting ferroptosis of prostate cancer cells by regulating the mevalonate pathway.European journal of histochemistry : EJH · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer is one of the most prevalent cancers, with 80%-85% of cases being non-small cell lung cancer (NSCLC). Objectives: This study investigated the effect of cardiac troponin I (cTnI) on NSCLC cells and its molecular mechanism. Materials and Methods: The overexpression and knockdown of cTnI were performed in NSCLC cells using lentivirus. Expression assays to analyse gene mRNA levels were performed using RT- PCR, and Western blot was used to detect the protein expression. Cell proliferation capacity was tested using MTT and colony formation assays, and a Transwell Results: cTnI expression was increased in NSCLC tissue and cells. The overexpression of cTnI in NSCLC cells promoted their development, and the knockdown of cTnI inhibited the proliferation and migration of lung cancer cells. Additionally, cTnI promoted the expression of Notch and Kras proteins in lung cancer cells. The xenograft experiments in nude mice yielded the same results. Conclusion: Cardiac troponin I affects the proliferation and migration of NSCLC cells by promoting the expression of Notch and Kras proteins, and the knockdown of cTnI significantly inhibits the growth and development of NSCLC cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.